Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Bioharvest Sciences Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 89.1K | 129.0K | +39.9K (+44.8%) |
| Value | $545.4K | $802.6K | +$257.2K (+47.2%) |
New holders (2)
Institutions that held Bioharvest Sciences Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 7 | $43 | 0.00% |
| Royal Bank of Canada | 9 | $0 | 0.00% |
Sold out (0)
Institutions that held Bioharvest Sciences Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.